Drug Licence News

28 Aug 20269:30 pm

pharmaceuticals28 Aug 2026 · 9:30 pm9:30 pm

Maharashtra FDA Cancels Cipla Pune Unit Licence, Seizes Rs 11.19 Lakh Drug Stock

The Maharashtra FDA has canceled Cipla's Pune unit drug sale license due to irregularities related to Reactin Plus, leading to the seizure of drug stock worth R

28 Aug 20269:30 pm

pharmaceuticals28 Aug 2026 · 9:30 pm9:30 pm

Create visual

Maharashtra FDA Revokes Cipla Pune Unit's Drug Licence for Reactin Plus Violations

The Maharashtra Food and Drug Administration has revoked Cipla's drug license for its Pune unit due to violations in packaging and storage practices, specifical

Drug Licence News

#Drug Licence

Maharashtra FDA Cancels Cipla Pune Unit Licence, Seizes Rs 11.19 Lakh Drug Stock

Maharashtra FDA Revokes Cipla Pune Unit's Drug Licence for Reactin Plus Violations

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs